Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Beauty & Home | 1,456.2 | 1,321.0 | 1,376.0 | 1,446.2 | 1,333.0 | 1,278.2 | 1,291.5 | 1,522.4 |
| Pharma | 1,298.0 | 1,234.1 | 1,100.5 | 955.1 | 805.9 | 741.5 | 712.2 | 751.2 |
| Food + Beverage | 511.1 | 407.4 | 418.0 | 386.7 | 352.5 | 330.2 | 335.4 | 349.3 |
| Total revenues [+] | 3,227.2 | 2,929.3 | 2,859.7 | 2,764.8 | 2,469.3 | 2,330.9 | 2,317.1 | 2,597.8 |
| Products | 3,227.2 | 2,929.3 | 2,859.7 | 2,764.8 | 2,469.3 | 2,330.9 | | |
| Revenue growth [+] | 10.2% | 2.4% | 3.4% | 12.0% | 5.9% | 0.6% | -10.8% | 3.1% |
| Beauty & Home | 10.2% | -4.0% | -4.9% | 8.5% | 4.3% | -1.0% | -15.2% | 1.4% |
| Pharma | 5.2% | 12.1% | 15.2% | 18.5% | 8.7% | 4.1% | -5.2% | 5.9% |
| Food + Beverage | 25.4% | -2.5% | 8.1% | 9.7% | 6.7% | -1.5% | -4.0% | 8.0% |
| Other | | | | | | | -13.3% | 5.2% |
| Cost of goods sold | 2,070.5 | 1,842.8 | 1,818.4 | 1,813.0 | 1,603.1 | 1,496.2 | 1,502.7 | 1,755.3 |
| Gross profit | 1,156.7 | 1,086.5 | 1,041.3 | 951.8 | 866.2 | 834.8 | 814.5 | 842.5 |
| Gross margin | 35.8% | 37.1% | 36.4% | 34.4% | 35.1% | 35.8% | 35.2% | 32.4% |
| Selling, general and administrative | 258.1 | 246.8 | 215.0 | 235.6 | 155.3 | 154.8 | 138.9 | 152.2 |
| Equity in earnings | -0.7 | -1.4 | 0.1 | -0.2 | -0.2 | -0.2 | -0.7 | 1.9 |
| Other operating expenses | 290.4 | 248.2 | 239.6 | 194.4 | 232.1 | 211.5 | 212.6 | 231.7 |
| EBITDA [+] | 607.5 | 590.1 | 586.9 | 521.6 | 478.6 | 468.3 | 462.3 | 460.6 |
| EBITDA growth | 3.0% | 0.5% | 12.5% | 9.0% | 2.2% | 1.3% | 0.4% | 3.4% |
| EBITDA margin | 18.8% | 20.1% | 20.5% | 18.9% | 19.4% | 20.1% | 20.0% | 17.7% |
| Depreciation | 193.8 | 180.5 | 166.9 | 156.3 | 142.8 | 145.5 | 134.6 | 146.9 |
| EBITA | 413.7 | 409.6 | 419.9 | 365.3 | 335.8 | 322.8 | 327.7 | 313.7 |
| EBITA margin | 12.8% | 14.0% | 14.7% | 13.2% | 13.6% | 13.8% | 14.1% | 12.1% |
| Amortization of intangibles | 41.1 | 39.8 | 27.6 | 15.5 | 10.3 | 9.3 | 4.2 | 5.3 |
| EBIT [+] | 372.7 | 369.8 | 392.3 | 349.9 | 325.5 | 313.5 | 323.4 | 308.3 |
| EBIT growth | 0.8% | -5.7% | 12.1% | 7.5% | 3.8% | -3.1% | 4.9% | 4.3% |
| EBIT margin | 11.5% | 12.6% | 13.7% | 12.7% | 13.2% | 13.4% | 14.0% | 11.9% |
| Non-recurring items | 26.0 | 31.7 | 20.5 | 63.8 | 2.2 | | | |
| Interest expense, net [+] | 26.6 | 32.3 | 31.3 | 25.6 | 35.1 | 32.6 | 29.0 | 16.2 |
| Interest expense | 30.3 | 33.2 | 35.5 | 32.6 | 40.6 | 35.2 | 34.6 | 21.0 |
| Interest income | 3.7 | 1.0 | 4.2 | 7.1 | 5.5 | 2.6 | 5.6 | 4.8 |
| Other income (expense), net | 1.6 | -4.6 | 1.6 | 5.5 | 6.7 | -0.4 | 0.2 | -5.8 |
| Pre-tax income | 321.7 | 301.2 | 342.1 | 266.0 | 294.8 | 280.5 | 294.6 | 286.3 |
| Income taxes | 78.0 | 87.1 | 99.8 | 71.3 | 74.8 | 74.9 | 95.3 | 94.7 |
| Tax rate | 24.3% | 28.9% | 29.2% | 26.8% | 25.4% | 26.7% | 32.3% | 33.1% |
| Minority interest | 0.5 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 |
| Net income | 244.1 | 214.0 | 242.2 | 194.7 | 220.0 | 205.6 | 199.3 | 191.7 |
| Net margin | 7.6% | 7.3% | 8.5% | 7.0% | 8.9% | 8.8% | 8.6% | 7.4% |
| |
| Basic EPS [+] | $3.72 | $3.32 | $3.81 | $3.12 | $3.52 | $3.27 | $3.19 | $2.95 |
| Growth | 11.9% | -12.8% | 22.1% | -11.5% | 7.7% | 2.8% | 8.0% | 13.3% |
| Diluted EPS [+] | $3.61 | $3.21 | $3.66 | $3.00 | $3.41 | $3.17 | $3.09 | $2.85 |
| Growth | 12.3% | -12.3% | 22.1% | -12.0% | 7.4% | 2.6% | 8.5% | 12.9% |
| |
| Dividends per share [+] | $1.50 | $1.44 | $1.42 | $1.32 | $1.28 | $1.22 | $1.14 | $1.09 |
| Growth | 4.2% | 1.4% | 7.7% | 3.0% | 4.9% | 7.2% | 4.1% | 9.3% |
| |
| Shares outstanding (basic) [+] | 65.7 | 64.4 | 63.6 | 62.4 | 62.4 | 62.8 | 62.6 | 65.0 |
| Growth | 1.9% | 1.3% | 1.8% | 0.0% | -0.6% | 0.3% | -3.7% | -1.6% |
| Shares outstanding (diluted) [+] | 67.7 | 66.7 | 66.2 | 65.0 | 64.6 | 64.8 | 64.5 | 67.3 |
| Growth | 1.5% | 0.8% | 1.8% | 0.6% | -0.4% | 0.6% | -4.2% | -1.3% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|